Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by Multiple Sclerosis Ireland .
Filed returns
57
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| Sep–Dec 2016 | Multiple Sclerosis Ireland | Health | Sativex - availability of licensed MS medication (Matters involving public funds) | 1 | On lobbying.ie |
| May–Aug 2016 | Multiple Sclerosis Ireland | Health | Advocacy work regarding the MS medication Fampyra (Matters involving public funds) | 1 | On lobbying.ie |
| May–Aug 2016 | Multiple Sclerosis Ireland | Health | Advocacy work relating to the cannabis-based MS medication Sativex (Matters involving public funds) | 2 | On lobbying.ie |
| Jan–Apr 2016 | Multiple Sclerosis Ireland | Health | Letter to Tony O'Brien regarding availability of MS medications that are currently only available via individual hospital budgets (Matters involving public funds) | 1 | On lobbying.ie |
| Jan–Apr 2016 | Multiple Sclerosis Ireland | Health | Question raised to the Director General of the HSE on the issue of underfunding for neurology services, via the National Patients' Forum (Matters involving public funds) | 1 | On lobbying.ie |
| Jan–Apr 2016 | Multiple Sclerosis Ireland | Health | Communication with the HSE regarding the systems for the reimbursement of the MS medication Fampyra. (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2016 | Multiple Sclerosis Ireland | Health | Reimbursement of MS medication Sativex (Matters involving public funds) | 2 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 57 | 100.0% |